About Genetikode

Precision genomics built for oncology decisions that matter.

Genetikode is a precision oncology company focused on transforming cancer diagnostics through integrated genomics and epigenomics.
We combine DNA, RNA, and methylation science with AI-powered software to generate clinically actionable insights faster.
Our platform supports screening, monitoring, variant interpretation, and scalable molecular reporting workflows.
We work at the intersection of research rigor, clinical utility, and digital innovation.
Our mission is to make next-generation oncology diagnostics more accurate, accessible, and impact-driven.

What We Build

Integrated products for laboratories, clinicians, and translational teams

Comprehensive Cancer Testing

Methylation-based screening and DNA/RNA oncology panels designed for robust detection and longitudinal monitoring.

AI-Native Bioinformatics

End-to-end software workflows for WGS, WES, panel analysis, RNA-seq, and methylation analytics with strong QC controls.

Clinical Interpretation

Evidence-aware ACMG classification support and report-ready outputs aligned with real-world diagnostic operations.